tirzepatide after gastric sleeve Real Patient Before and Results for Medical Weight Loss and Bariatric Surgery Tirzepatide & Semaglutide Weight Loss

A review published in Obesity Reviews in 2024 highlights that long-term GLP-1 users present a risk profile comparable to patients post-bariatric surgery regarding these micronutrients

If you experienced semaglutide acid reflux or bloating during treatment, track whether these symptoms change during the taper

PMID: 23034130

Stirnberg, P., van De Sande, K

The ideal candidates are typically adults with a BMI in the overweight or obese category, who have struggled to lose weight through diet and exercise alone

Kidney health protection GLP-1s have shown promising results in protecting kidney function, especially in patients with type 2 diabetes and chronic kidney disease